Teradyne (TER) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue reached $737 million, up 4.8%–5% year-over-year, exceeding guidance, driven by strong AI-related demand in compute and memory test markets, with record HBM DRAM revenue and robust Robotics growth.

• SemiTest business outperformed, with memory segment achieving record-high revenue due to HBM demand, while Robotics delivered 8% year-to-date growth and expanded OEM channels.

• Strategic actions included a $524.1M Technoprobe investment for a 10% stake and the sale of the Device Interface Solutions business for $85M, resulting in a $57.5M pre-tax gain.

• Gross margin improved to 59.7% (non-GAAP), above guidance, due to favorable product mix and volume.

• AI is identified as a transformational growth driver across both test and robotics segments.

Financial highlights

• Q3 2024 revenue was $737M (Q3 2023: $704M; Q2 2024: $730M); non-GAAP EPS was $0.90, above guidance; GAAP EPS was $0.89.

• Non-GAAP gross margin was 59.7%; GAAP gross margin was 59.2%.

• Non-GAAP operating profit was $165M (22.4% of sales); GAAP operating income was $152.1M (20.6% margin).

• Free cash flow for Q3 was $114M; cash, cash equivalents, and marketable securities totaled $677.6M at quarter end.

• Q3 2024 dividend payout was $20M; share repurchases totaled $24.7M–$25M.

Outlook and guidance

• Q4 2024 sales expected between $710M and $760M; non-GAAP EPS guidance of $0.80–$0.97; GAAP EPS $0.73–$0.91.

• Robotics growth for 2024 expected at 5%–10%, targeting 15%–20% above peer group.

• Revenue growth in 2025 anticipated to accelerate, with OpEx planned to increase low teens year-over-year.

• SOC TAM for 2024 expected at ~$4.2B; Compute TAM raised to $1.8B, Memory Test TAM to $1.4B.

• Management anticipates sufficient liquidity to meet operational and capital needs for at least the next twelve months.